FDA Warning Letter — Breckenridge Pharmaceutical, Inc.
The FDA took a Warning Letter action against Breckenridge Pharmaceutical, Inc. on Feb 9, 2010 (Boca Raton, FL). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Breckenridge Pharmaceutical, Inc.
- Date
- Feb 9, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Center
- CDER
- Location
- Boca Raton, FL (United States)